Work

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.

Year: 1998

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1998.16.9.3053

Authors: N K Cheung, B H Kushner, I Y Cheung, K Kramer, A Canete, W Gerald, M A Bonilla, R Finn, S J Yeh, S M Larson

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: NOVEL COMBINATION THERAPY OF NEUROBLASTOMA, G1836322885

OpenAlex ID: W1940650862

FWCI: 7.173

Cites: 25

Cited by: 196

Related to: 10